company background image
WST

West Pharmaceutical Services NYSE:WST Stock Report

Last Price

US$236.03

Market Cap

US$17.5b

7D

-2.5%

1Y

-45.0%

Updated

08 Dec, 2022

Data

Company Financials +
WST fundamental analysis
Snowflake Score
Valuation2/6
Future Growth1/6
Past Performance3/6
Financial Health6/6
Dividends0/6

WST Stock Overview

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.

West Pharmaceutical Services, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for West Pharmaceutical Services
Historical stock prices
Current Share PriceUS$236.03
52 Week HighUS$475.00
52 Week LowUS$206.19
Beta1.14
1 Month Change5.11%
3 Month Change-24.71%
1 Year Change-45.01%
3 Year Change61.21%
5 Year Change140.26%
Change since IPO4,901.96%

Recent News & Updates

Why West Pharmaceutical Services, Inc. (NYSE:WST) Could Be Worth Watching

Nov 29
Why West Pharmaceutical Services, Inc. (NYSE:WST) Could Be Worth Watching

Recent updates

Why West Pharmaceutical Services, Inc. (NYSE:WST) Could Be Worth Watching

Nov 29
Why West Pharmaceutical Services, Inc. (NYSE:WST) Could Be Worth Watching

West Pharmaceutical Services (NYSE:WST) Seems To Use Debt Rather Sparingly

Oct 25
West Pharmaceutical Services (NYSE:WST) Seems To Use Debt Rather Sparingly

Is West Pharmaceutical Services, Inc. (NYSE:WST) Expensive For A Reason? A Look At Its Intrinsic Value

Sep 14
Is West Pharmaceutical Services, Inc. (NYSE:WST) Expensive For A Reason? A Look At Its Intrinsic Value

Is There Now An Opportunity In West Pharmaceutical Services, Inc. (NYSE:WST)?

Aug 31
Is There Now An Opportunity In West Pharmaceutical Services, Inc. (NYSE:WST)?

Do West Pharmaceutical Services' (NYSE:WST) Earnings Warrant Your Attention?

Aug 18
Do West Pharmaceutical Services' (NYSE:WST) Earnings Warrant Your Attention?

Is West Pharmaceutical Services (NYSE:WST) Using Too Much Debt?

Jul 27
Is West Pharmaceutical Services (NYSE:WST) Using Too Much Debt?

West Pharmaceutical Services, Inc. (NYSE:WST) Shares Could Be 32% Above Their Intrinsic Value Estimate

Jun 09
West Pharmaceutical Services, Inc. (NYSE:WST) Shares Could Be 32% Above Their Intrinsic Value Estimate

Should You Think About Buying West Pharmaceutical Services, Inc. (NYSE:WST) Now?

May 20
Should You Think About Buying West Pharmaceutical Services, Inc. (NYSE:WST) Now?

Does West Pharmaceutical Services (NYSE:WST) Deserve A Spot On Your Watchlist?

May 05
Does West Pharmaceutical Services (NYSE:WST) Deserve A Spot On Your Watchlist?

We Think West Pharmaceutical Services (NYSE:WST) Can Manage Its Debt With Ease

Apr 22
We Think West Pharmaceutical Services (NYSE:WST) Can Manage Its Debt With Ease

Should You Investigate West Pharmaceutical Services, Inc. (NYSE:WST) At US$400?

Feb 11
Should You Investigate West Pharmaceutical Services, Inc. (NYSE:WST) At US$400?

West Pharmaceutical Services (NYSE:WST) Has A Rock Solid Balance Sheet

Jan 11
West Pharmaceutical Services (NYSE:WST) Has A Rock Solid Balance Sheet

Why We Like The Returns At West Pharmaceutical Services (NYSE:WST)

Oct 25
Why We Like The Returns At West Pharmaceutical Services (NYSE:WST)

Here's Why I Think West Pharmaceutical Services (NYSE:WST) Is An Interesting Stock

Oct 11
Here's Why I Think West Pharmaceutical Services (NYSE:WST) Is An Interesting Stock

West Pharmaceutical Services (NYSE:WST) Seems To Use Debt Rather Sparingly

Sep 13
West Pharmaceutical Services (NYSE:WST) Seems To Use Debt Rather Sparingly

What Does West Pharmaceutical Services, Inc.'s (NYSE:WST) Share Price Indicate?

Aug 02
What Does West Pharmaceutical Services, Inc.'s (NYSE:WST) Share Price Indicate?

Investors Shouldn't Overlook West Pharmaceutical Services' (NYSE:WST) Impressive Returns On Capital

Jul 20
Investors Shouldn't Overlook West Pharmaceutical Services' (NYSE:WST) Impressive Returns On Capital

Do West Pharmaceutical Services's (NYSE:WST) Earnings Warrant Your Attention?

Jul 05
Do West Pharmaceutical Services's (NYSE:WST) Earnings Warrant Your Attention?

We Think West Pharmaceutical Services (NYSE:WST) Can Manage Its Debt With Ease

Jun 08
We Think West Pharmaceutical Services (NYSE:WST) Can Manage Its Debt With Ease

We Think Shareholders Will Probably Be Generous With West Pharmaceutical Services, Inc.'s (NYSE:WST) CEO Compensation

Apr 29
We Think Shareholders Will Probably Be Generous With West Pharmaceutical Services, Inc.'s (NYSE:WST) CEO Compensation

What Does West Pharmaceutical Services, Inc.'s (NYSE:WST) Share Price Indicate?

Apr 07
What Does West Pharmaceutical Services, Inc.'s (NYSE:WST) Share Price Indicate?

Can West Pharmaceutical Services (NYSE:WST) Continue To Grow Its Returns On Capital?

Mar 09
Can West Pharmaceutical Services (NYSE:WST) Continue To Grow Its Returns On Capital?

If You Like EPS Growth Then Check Out West Pharmaceutical Services (NYSE:WST) Before It's Too Late

Feb 23
If You Like EPS Growth Then Check Out West Pharmaceutical Services (NYSE:WST) Before It's Too Late

West Pharmaceutical Services (NYSE:WST) Seems To Use Debt Rather Sparingly

Feb 09
West Pharmaceutical Services (NYSE:WST) Seems To Use Debt Rather Sparingly

West Pharmaceutical Services, Inc.'s (NYSE:WST) Stock Has Fared Decently: Is the Market Following Strong Financials?

Jan 27
West Pharmaceutical Services, Inc.'s (NYSE:WST) Stock Has Fared Decently: Is the Market Following Strong Financials?

Investors Who Bought West Pharmaceutical Services (NYSE:WST) Shares Five Years Ago Are Now Up 423%

Jan 13
Investors Who Bought West Pharmaceutical Services (NYSE:WST) Shares Five Years Ago Are Now Up 423%

Is West Pharmaceutical Services, Inc. (NYSE:WST) Potentially Undervalued?

Dec 29
Is West Pharmaceutical Services, Inc. (NYSE:WST) Potentially Undervalued?

Need To Know: West Pharmaceutical Services, Inc. (NYSE:WST) Insiders Have Been Selling Shares

Dec 15
Need To Know: West Pharmaceutical Services, Inc. (NYSE:WST) Insiders Have Been Selling Shares

Can West Pharmaceutical Services (NYSE:WST) Continue To Grow Its Returns On Capital?

Dec 01
Can West Pharmaceutical Services (NYSE:WST) Continue To Grow Its Returns On Capital?

Shareholder Returns

WSTUS Life SciencesUS Market
7D-2.5%-1.5%-2.8%
1Y-45.0%-27.3%-19.6%

Return vs Industry: WST underperformed the US Life Sciences industry which returned -29% over the past year.

Return vs Market: WST underperformed the US Market which returned -21.2% over the past year.

Price Volatility

Is WST's price volatile compared to industry and market?
WST volatility
WST Average Weekly Movement7.9%
Life Sciences Industry Average Movement11.1%
Market Average Movement7.4%
10% most volatile stocks in US Market15.5%
10% least volatile stocks in US Market3.3%

Stable Share Price: WST is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 8% a week.

Volatility Over Time: WST's weekly volatility (8%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
192310,065Eric Greenhttps://www.westpharma.com

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components.

West Pharmaceutical Services, Inc. Fundamentals Summary

How do West Pharmaceutical Services's earnings and revenue compare to its market cap?
WST fundamental statistics
Market CapUS$17.47b
Earnings (TTM)US$630.60m
Revenue (TTM)US$2.91b

27.7x

P/E Ratio

6.0x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
WST income statement (TTM)
RevenueUS$2.91b
Cost of RevenueUS$1.73b
Gross ProfitUS$1.17b
Other ExpensesUS$544.10m
EarningsUS$630.60m

Last Reported Earnings

Sep 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)8.52
Gross Margin40.38%
Net Profit Margin21.68%
Debt/Equity Ratio8.5%

How did WST perform over the long term?

See historical performance and comparison

Dividends

0.3%

Current Dividend Yield

9%

Payout Ratio